JANX FY 2022 Earnings — Janux Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

JANXJanux Therapeutics, Inc.

$852M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9M+136.8% YoY

Gross Profit

$8M90.2% margin

Operating Income

-$67M-779.0% margin

Net Income

-$63M-732.2% margin

EPS (Diluted)

$-1.52

Cash Flow

Operating Cash Flow

-$43M

Free Cash Flow

-$49M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$364M

Total Liabilities

$43M

Stockholders' Equity

$321M

Cash & Equivalents

$51M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$4M	+136.8%
Gross Profit	$8M	$4M	+113.7%
Operating Income	-$67M	-$33M	-103.7%
Net Income	-$63M	-$33M	-93.0%